AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • March 7th, 2006 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AMENDMENT TO DEVELOPMENT AND LICENSE AGREEMENT (the “Amendment”) is entered into as of October 24, 2005 (the “Amendment Effective Date”) by and between AMYLIN PHARMACEUTICALS, INC., a Delaware corporation (“Amylin”), and ALKERMES CONTROLLED THERAPEUTICS INC. II, a Pennsylvania corporation (“ACTII”).
